The Library
ARTemis : a randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer
Tools
(2015) ARTemis : a randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer. Cancer Research, 75 (9). doi:10.1158/1538-7445.SABCS14-PD2-3
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: https://doi.org/10.1158/1538-7445.SABCS14-PD2-3
Item Type: | Journal Item | ||||
---|---|---|---|---|---|
Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) | ||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Journal or Publication Title: | Cancer Research | ||||
Publisher: | American Association of Cancer Research | ||||
ISSN: | 0008-5472 | ||||
Official Date: | 1 May 2015 | ||||
Dates: |
|
||||
Volume: | 75 | ||||
Number: | 9 | ||||
DOI: | 10.1158/1538-7445.SABCS14-PD2-3 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |